Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 75 of 1710 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/20/22
Due: 07/20/23
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 03/08/22
Due: 03/08/23
Phase: N/A
Priority: Normal
Start: 08/09/22
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 10/01/19
Due: 10/01/20
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 06/07/16
Due: 06/07/17
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 03/30/19
End: 03/30/28
Due: 03/30/29
Phase: N/A
Priority: Normal
Start: 06/17/15
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 12/22/23
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 06/30/16
Due: 06/30/17
Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 03/31/21
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 05/07/19
End: 04/22/21
Due: 04/22/22
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/31/18
End: 03/30/20
Due: 03/30/21